Apalutamide Recruiting Phase 2 Trials for Newly Diagnosed Oligometastatic Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03298087Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer